Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.


TSXV:VM - Post by User

Comment by biggdoggon Sep 19, 2023 11:56am
120 Views
Post# 35643509

RE:RE:Chinese Barite

RE:RE:Chinese BariteThere will be no Frances creek barite produced until they build a quarry, build a plant to process the barite into pharma barium sulfate. That is what the PEA was all about. It laid out the $36M required to get the project into production. They are reliant on using man made barite until FC is producing. Once FC is financed, I would suspect the stock will begin to trend up toward the $344M valuation. They have not done any small nickle and dime financings, that would indicate to me they are working on something larger? Its a mine, you need to dig it out, crush it, seperate the barite out into a high grade concentrate, ship it to a mill, grind and clean out the fine waste from the barite, and because its pharma, it needs to be done in a way that passes GMP Heath Canada and FDA processing standards. Then it goes into bottles. The last I heard they are buying man made for $6,000-$17,000 a ton? The PEA said it cost Voy less than $500 I think? 
<< Previous
Bullboard Posts
Next >>